ArticleImatinib Mesylate–Induced Lichenoid Drug EruptionAuthor:Erin H. Penn, MDPublish date: March 6, 2017Imatinib mesylate (imatinib) is a tyrosine kinase inhibitor initially approved by the US Food and Drug Administration in 2001 for chronic myeloid l...Read More
QuizDiffuse Crusting of the SkinAuthor:Erin H. Penn, MDPublish date: August 17, 2015An 82-year-old white man who resided in the northeastern United States was admitted to the hospital for weakness. He was evaluated for diffuse crus...Read More
